On the influence of the instillation time on the results of HAL (Hexvix®) fluorescence detection of superficial bladder cancer

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 5141, Issue , 2003, Pages 272-277

  Jichlinski, P ^a   Aymon, D ^a   Wagnieres G ^b   Marti, A ^a   Lange, N ^b   Guillou, L ^a   Leisinger, H J ^a   Van Den Bergh, H ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

Aminolevulinic acid hexylester; Bladder; Cancer detection; Carcinoma in situ; Fluorescence cystoscopy; Instillation time

Indexed keywords

BIOPSY; DISEASES; FLUORESCENCE; HEALTH RISKS; IMAGING SYSTEMS; ONCOLOGY; PATIENT TREATMENT;

CANCER DETECTION; CARCINOMA; HEXYL AMINOLEVULINATE FLUORESCENCE CYSTOSCOPY; INSTILLATION TIME; SUPERFICIAL BLADDER CANCER;

BIOMEDICAL ENGINEERING;

EID: 1342310456     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.502218     Document Type: Conference Paper

References (20)

1. Landis SH., Murray T., Borden S., Wingo PA.: Cancer Statistics. CA Cancer J Clin, 49 : 8, 1999.
2. Bray, F., Sankila R., Ferlay, J., Parkin DM.: Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer, 38 : 99, 2002.
3. Herr HW. Natural history of superficial bladder tumours: 10- to 20-year follow-up of treated patients. World J Urol, 15 : 84 1997.
4. Droller MJ. Bladder cancer: state-of-the-art care. CA Cancer J Clin, 48 : 269, 1998.
5. Kriegmair M., Baumgartner R., Knuchel R., Stepp H., Hofstadter F., Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol, 155 : 105, 1996.
6. Jichlinski P., Forrer M., Mizeret J., Glanzmann, T., Braichotte D., Wagnières G. et al. Clinical evaluation of a method for detecting superficial transitional cell carcinoma cell carcinoma of the bladder by light induced flourescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med, 20 : 402, 1997.
7. Koenig F, McGovern FJ, Larne R, Enquist H, Schomacker KT, Deutsch TF. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. Br J Urol, 83 : 129, 1999.
8. Jichlinski P, Guillou L, Karlsen S et al. Hexyl aminolevulinate fluorescence crystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer - a multicentric study. The Journal of Urology, 170, 2003.
9. Marti A, Lange N, van den Bergh H, Sedmera D, Jichlinski P, Kucera P. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol, 162 : 546, 1999.
10. Lange N, Jichlinski P, Zellweger M, Forrer M, Marti A, Guillou L., et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer, 80 : 185, 1999.
11. Jichlinski P, Marti A, Aymon D., Lange N., Wagnières, G., Guillou L, Leisinger H-J. Hexyl-ester aminolevulinic acid induced fluorescence cystoscopy in patients with superficial bladder cancer. J Urol, 167(Suppl): 160, abstract 644, 2002.
12. Mostofi FK, Sobin LH, Torloni H. Histopathological typing of urinary bladder tumours. In: World Health Organisation, International histological classification of tumours. Geneva: World Health Organisation, 1973.
13. Hermanek J, Sobin J. UICC TNM classification of malignant tumours. 4th ed. 1992, Berlin: Springer Verlag.
14. de Vere White RW, Stapp E. Predicting prognosis in patients with superficial bladder cancer Oncology, 12 : 1717, 1998.
15. Richards B, Parmar MK, Anderson CK, Ansell ID., Grigor K., Hall R.R., et al. Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. Br J Urol 67 : 369, 1991.
16. Kiemeney LALM, Witjes JA, Heijbroek RP, Koper NP, Verbeek ALM, Debruyne FMJ and the Members of the Dutch South-East-Co-operative Urological Group. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br J Urol 73 : 164, 1994.
17. See WA, Williams RD. Urothelial injury and clotting cascade activation: common denominators in particulate adherence to urothelial surfaces. J Urol, 147 : 451, 1992.
18. Kriegmair M, Zaak D, Hofstetter AG, Rothenberger KH., Rassweiler J., Jocham D. et al. Transurethral resection of bladder cancer controlled by 5-aminolevulinic acid induced fluorescence endoscopy (AFE) versus white light endoscopy. J Urol, 163(Suppl) : 149 abstract 664, 2000.
19. Riedl CR, Daniltchenko D Koenig F, Simak R, Loening SA, Pflueger H. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol, 165 : 1121, 2001.
20. Filbeck T., Pichlmeier U., Knuechel R., Wieland WF., Roessler W. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol, 168 : 67, 2002.